PALB2 and hypoparathyroidism-retardation-dysmorphism syndrome: The incidence of biallelic pathogenic mutations in PALB2 and RAD51 paralog C (RAD51C) is observed to be significantly higher in HRD, and the inactivation of these two genes have been demonstrated in previous studies as the major genetic basis of human HRD29–31.